D
Zevra Therapeutics, Inc. ZVRA
$8.31 $0.374.66%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -35.74M -33.23M -19.93M -16.62M -19.89M
Total Depreciation and Amortization 1.65M 1.62M 1.56M 1.56M 787.00K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 22.65M 13.71M 694.00K -957.00K 5.49M
Change in Net Operating Assets -4.81M -239.00K -1.44M -148.00K -2.54M
Cash from Operations -16.25M -18.14M -19.11M -16.17M -16.16M
Capital Expenditure -- -- -- -- -72.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- -30.40M
Divestitures -- -- -- -- --
Other Investing Activities -5.47M -31.35M -129.00K 14.79M 41.06M
Cash from Investing -5.47M -31.35M -129.00K 14.79M 10.59M
Total Debt Issued 0.00 0.00 60.07M -- 3.63M
Total Debt Repaid 0.00 0.00 -43.13M -- -4.73M
Issuance of Common Stock 796.00K 64.77M 480.00K 1.22M 6.11M
Repurchase of Common Stock -- -- -- -- 0.00
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 0.00 0.00 -2.09M -- --
Cash from Financing 796.00K 64.77M 15.33M 1.22M 5.00M
Foreign Exchange rate Adjustments 671.00K -491.00K 319.00K -45.00K 349.00K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -20.25M 14.78M -3.59M -200.00K -220.00K
Weiss Ratings